Additional file 2 of MED12 mutation as a potential predictive biomarker for immune checkpoint inhibitors in pan-cancerYong Zhou, Yuan Tan, Qin Zhang, Qianqian Duan & Jun Chen
Additional file 2: Fig. S2. The pan-cancer landscape of MED12 mutations across human tumors. The proportion of MED12 mutated tumors identified for each cancer type with alteration frequency in TCGA pan-cancer cohorts.
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.